At CRG, our mission is to improve patient lives, reduce healthcare costs, and expand access to care. We are committed to ensuring that all our portfolio companies achieve at least one of these critical initiatives, driving meaningful change and fostering a healthier future for communities worldwide.
We are a leading healthcare private credit firm, managing over $4 billion in institutional capital and having led over 80 healthcare investments.
We provide growth capital ranging from $20 million to $300 million to innovative healthcare companies across various sectors including services, medical devices, tools and diagnostics, biopharmaceuticals, information technology, and health and wellness.
All loans are first-lien and senior secured to minimize dilution and support companies' growth objectives while maintaining their equity ownership.
We are an attractive partner to both public and private companies due to our flexible financing solutions, long-standing track record of support to achieve robust growth objectives.
At CRG, we offer a compelling financing alternative geared towards a long-term partnership, leveraging our depth of healthcare industry expertise.
Our growth capital solution is more cost-effective and less dilutive than traditional equity financing and provides greater flexibility and fewer restrictions compared to other funding sources.
Our approach emphasizes becoming a trusted long-term partner to companies, offering extensive support beyond financial investment, leveraging our finance team, Strategic Advisory Board, and global network of industry experts.
We facilitate strategic and financial guidance, advocate for companies with potential investors and sponsors, and connect them with industry leaders to enhance their market position and growth prospects.
Our capital and expertise enables portfolio companies to enhance their growth trajectory while retaining control of the business.
Our capital allows companies to utilize current cash flows for various growth initiatives, such as product launches, market expansions, acquisitions, and strategic R&D, all while preserving operational independence.
Targeting a $500 billion market opportunity across 7,000 small to mid-sized healthcare firms, we invest in market leaders, spanning services, medical devices, tools and diagnostics, biopharmaceuticals, information technology, and health and wellness.
We collaborate closely with management teams, leveraging our global network to identify high-quality investment opportunities and support growth initiatives worldwide.
As experienced partners, we not only offer strategic guidance and operational support but also connect companies with key equity sponsors, strategic partners, and industry experts.
We utilize a broad network of industry relationships to identify healthcare trends, source exclusive investment opportunities, conduct thorough due diligence, mitigate risks, and provide ongoing value post-investment.
With a track record through multiple cycles in healthcare credit, we have pioneered financings for many significant industry innovations in a range of different environments.
Leveraging our investment team and industry connections, we offer strategic, operational, and financial guidance, facilitate introductions to equity sponsors and strategic partners, and provide access to industry experts, key opinion leaders, and regulatory consultants.
Our portfolio includes renowned healthcare market leaders, providing invaluable industry insights and attracting high-quality investment opportunities.
We believe balancing environmental, social and governance issues with financial priorities is fundamental to sound risk management.
At CRG, we recognize that incorporating ESG can enhance the investment process and lead to better outcomes, without compromising returns and potentially enhancing them.
As a part of our commitment to sustainability, CRG is a signatory to the UN-supported Principles for Responsible Investing.
With offices located in Houston, Boulder, and New York, we are positioned to effectively serve the diverse needs of our partners across the healthcare industry and ensures that we can provide localized expertise and support to investors and portfolio companies.